IP Library Granted Patent US 8,242,254
Granted Patent B2
US 8,242,254 · App. 11/683,311 · Granted Aug 14, 2012

Compositions for use in identification of bacteria

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,242,254
App. No.
11/683,311
Granted
Aug 14, 2012
Kind
B2
Abstract

The present invention provides compositions, kits and methods for rapid identification and quantification of bacteria by molecular mass and base composition analysis.

Claims (14)

1. An oligonucleotide primer pair comprising a forward and a reverse primer, wherein said forward primer comprises a sequence 98% identical to SEQ ID NO: 418, and said reverse primer comprises a sequence 98% identical to SEQ ID NO: 1301.

2. The oligonucleotide primer pair of claim 1 wherein said forward primer is SEQ ID NO: 418.

3. The oligonucleotide primer pair of claim 1 wherein said reverse primer is SEQ ID NO: 1301.

4. The oligonucleotide primer pair of claim 1 wherein at least one of said forward primer and said reverse primer comprises at least one modified nucleobase.

5. The oligonucleotide primer pair of claim 4 wherein at least one of said at least one modified nucleobase is a mass modified nucleobase.

6. The oligonucleotide primer pair of claim 5 wherein said mass modified nucleobase is 5-Iodo-C.

7. The composition of claim 5 wherein said mass modified nucleobase comprises a molecular mass modifying tag.

8. The oligonucleotide primer pair of claim 4 wherein at least one of said at least one modified nucleobase is a universal nucleobase.

9. The oligonucleotide primer pair of claim 8 wherein said universal nucleobase is inosine.

10. The oligonucleotide primer pair of claim 1 wherein at least one of said forward primer and said reverse primer comprises a non-templated T residue at its 5′ end.

11. A kit for identifying, determining one or more characteristics of, or detecting a Staphylococcus aureus bioagent comprising the oligonucleotide primer pair of claim 1 and at least one additional primer pair designed to hybridize to a Staphylococcus aureus gene encoding arcC, aroE, gmk, tpi, yqi, or a combination thereof.

12. The kit of claim 11 further comprising at least one other additional primer pair designed to hybridize to a Staphylococcus aureus gene encoding mecA, mecR1, pvluk, or a combination thereof.

13. The kit of claim 11 wherein said at least one additional primer pair comprises SEQ ID NOs: 437:1232, SEQ ID NOs:590:891, SEQ ID NOs:474:869, SEQ ID NOs: 268:1284, SEQ ID NOs: 318:1300, SEQ ID NOs: 440:1076, SEQ ID NOs: 219:1013, or a combination thereof.

14. The kit of claim 11 wherein said oligonucleotide primer pair of claim 1 and said at least one additional primer pair consists of eight oliconucleotide primer pairs having at least 70% sequence identity with the primer pairs represented by SEQ ID NOs: 437:1232, SEQ ID NOs: 590:891, SEQ ID NOs: 474:869, SEQ ID NOs: 268:1284, SEQ ID NOs: 418:1301, SEQ ID NOs: 318:1300, SEQ ID NOs: 440:1076, and SEQ ID NOs: 219:1013.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2007
From: ISIS PHARMACEUTICALS, INC.
To: IBIS BIOSCIENCES, INC.
Reel/Frame 019690/0071 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2007
From: SAMPATH, RANGARAJAN; HALL, THOMAS A.; ECKER, DAVID J.; BLYN, LAWRENCE
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 019315/0991 →